Search hospitals > New York > New York
Columbia University
Claim this profileNew York, New York 10032
Global Leader in Alzheimer's Disease
Global Leader in Cancer
Conducts research for Diabetes
Conducts research for Breast Cancer
Conducts research for Human Immunodeficiency Virus Infection
629 reported clinical trials
83 medical researchers
Summary
Columbia University is a medical facility located in New York, New York. This center is recognized for care of Alzheimer's Disease, Cancer, Diabetes, Breast Cancer, Human Immunodeficiency Virus Infection and other specialties. Columbia University is involved with conducting 629 clinical trials across 752 conditions. There are 83 research doctors associated with this hospital, such as Richard Carvajal, MD, Mark N. Stein, Ran Reshef, MD, and Fabio Iwamoto, MD.Area of expertise
1Alzheimer's Disease
Global LeaderAPOE4 positive
2Cancer
Global LeaderStage IV
Stage III
BRCA positive
Top PIs
Richard Carvajal, MDColumbia University Medical Center-CUIMC Herbert Irving Comprehensive Cancer Center Clinical Protoco2 years of reported clinical research
Studies Solid Tumors
Studies Tumors
20 reported clinical trials
60 drugs studied
Mark N. SteinColumbia University Irving Medical Center1 year of reported clinical research
Expert in Prostate Cancer
Studies Cancer
18 reported clinical trials
33 drugs studied
Ran Reshef, MDColumbia University Medical Center2 years of reported clinical research
Studies Lymphoma
Studies Leukemia
18 reported clinical trials
29 drugs studied
Fabio Iwamoto, MDColumbia University Medical Center2 years of reported clinical research
Studies Glioblastoma
Studies Brain Tumor
15 reported clinical trials
27 drugs studied
Clinical Trials running at Columbia University
Non-Small Cell Lung Cancer
Prostate Cancer
Non-Hodgkin's Lymphoma
Lymphoma
Cutaneous T-Cell Lymphoma
Acute Myeloid Leukemia
Obesity
Colorectal Cancer
Pancreatic Cancer
Peripheral T-Cell Lymphoma
RMC-6236
for Cancer
This trial is testing a new drug called RMC-6236, which is taken by mouth and targets a protein called RAS. It is aimed at adults with advanced cancers that have specific mutations in the RAS protein. The drug works by blocking this protein, which helps stop the cancer cells from growing.
Recruiting1 award Phase 14 criteria
H002
for Non-Small Cell Lung Cancer
This is a phase I/IIa, open-label, dose-escalation and expansion study to evaluate the safety, tolerability, PK and preliminary anti-tumor activity of H002 when given orally in patients with active EGFR mutation locally advanced or metastatic non-small cell lung cancer (NSCLC). The study will contain two parts: Part A is dose escalation phase (i.e., Phase I) and Part B is dose expansion phase (i.e., Phase IIa).
Recruiting1 award Phase 1 & 212 criteria
RMC-6291 + RMC-6236
for Advanced Solid Cancers
This study is to evaluate the safety, tolerability, and PK profiles of RMC-6291 and RMC-6236 in adults with KRAS G12C-mutated solid tumors.
Recruiting1 award Phase 110 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Columbia University?
Columbia University is a medical facility located in New York, New York. This center is recognized for care of Alzheimer's Disease, Cancer, Diabetes, Breast Cancer, Human Immunodeficiency Virus Infection and other specialties. Columbia University is involved with conducting 629 clinical trials across 752 conditions. There are 83 research doctors associated with this hospital, such as Richard Carvajal, MD, Mark N. Stein, Ran Reshef, MD, and Fabio Iwamoto, MD.
Where is Columbia University located?
The Columbia University Irving Medical Center is situated in the Washington Heights neighborhood of northern Manhattan, New York City, at West 168th Street and Broadway. It is easily accessible by public transportation, with the 1, A, or C subway lines stopping at the 168th Street station, along with several city bus routes. For those driving, the recommended approach is via the George Washington Bridge, exiting onto Riverside Drive, then proceeding to West 165th Street, and finally turning right onto Fort Washington Avenue to reach the medical center's parking facility.
Who should I call to ask about financial aid or insurance network?
For financial assistance at Columbia University Hospital, reach out to the Patient Financial Hardship department at 212-305-8400 or email PathBilling@cumc.columbia.edu for billing, insurance, or patient responsibility inquiries. For insurance-related questions, contact the Patient Accounting Department at 518.828.8051, available Monday-Friday, 8 a.m. to 4 p.m.
What insurance does Columbia University accept?
NewYork-Presbyterian Hospital, affiliated with Columbia University, accepts a range of insurance plans such as Aetna, Cigna, United Healthcare, and WellCare. Columbia University employees have access to four comprehensive medical plan options through UnitedHealthcare, which include vision and prescription drug coverage. Columbia University students benefit from dental and vision discounts under the Student Health Insurance Plan, administered by Aetna.
What awards or recognition has Columbia University received?
Columbia University Medical Center is renowned for its PTSD Research and Treatment Program, aimed at improving understanding of PTSD, trauma resilience, and developing neuroscience-informed treatments. It is also celebrated for its leadership in medical education, groundbreaking research, and innovative patient care, with its sponsored research reaching hundreds of millions annually.